SEP 15, 2020 4:43 PM PDT

How Can Genetic Data Make Informed Decisions About Drug Development?

WRITTEN BY: Nouran Amin

How Can Genetic Data Make Informed Decisions About Drug Development?

Scientists at the Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol created an innovative study involving the genetic analysis of blood protein levels. The study can help support drug target prioritization.

"This study lays a solid methodological foundation for future genetic studies of omics. The next step is for the analytical protocol to be used in early drug target validation pipeline by the study's pharmaceutical collaborators. We hope that these findings will support further drug development? to increase the success rate of drug trials, reduce drug cost and benefit patients," says Dr. Jie Zheng, lead author of the study. "This analysis pipeline could be used to validate both efficacy and potential adverse effects of novel drug targets, as well as provide evidence to repurpose existing drugs to other indications.”

Current genetic studies of proteins are in their infancy and the present research opens the doors to genetic predictions that prioritize drug targets.

Learn more about the role of genetics in drug development:

Genetic studies of proteins are in their infancy. The aim of this research, published in Nature Genetics, Findings were published in Nature Genetics and discusses how estimating the effects of proteins on human diseases can be used to make informed decisions on the effects of drugs that target those proteins.

Tom Gaunt, Professor of Health and Biomedical Informatics, University of Bristol, and a member of the NIHR Bristol Biomedical Research Centre, notes: "Our study used publicly available data published by many researchers around the world (collated by the MRC-IEU OpenGWAS database), and really demonstrates the potential of open data sharing in enabling novel discoveries in health research. We have demonstrated that this re-use of existing data offers an efficient approach to reducing drug development costs with anticipated benefits for health and society.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 25, 2020
Cannabis Sciences
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
AUG 25, 2020
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
The US Food and Drug Administration has approved Epidiolex, a cannabidiol (CBD) oral solution, to treat seizures linked ...
SEP 07, 2020
Microbiology
How THC Can Help Relieve a Respiratory Disorder
SEP 07, 2020
How THC Can Help Relieve a Respiratory Disorder
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the sacs in the lungs that hold air, and the l ...
SEP 29, 2020
Drug Discovery & Development
Cycling Molecules into Drug Candidates
SEP 29, 2020
Cycling Molecules into Drug Candidates
Statistics show that just 1 in 5,000 drug candidates ever makes it from the lab to the pharmacy. In a process that can t ...
SEP 03, 2020
Drug Discovery & Development
Combination of Cholesterol Lowering Drugs Effective in Reducing Heart Disease
SEP 03, 2020
Combination of Cholesterol Lowering Drugs Effective in Reducing Heart Disease
A recent European study found that individuals taking a combination of lipid-lowering therapeutics may reduce the risk o ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
Loading Comments...